AUROVELA FE 1/20
ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
Approval overview AUROVELA FE 1/20 is listed in Drugs@FDA under application 207505 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient ETHINYL ESTRADIOL; NORETHINDRONE ACETATE Form and strength TABLET;ORAL-28 - 0.02MG;1MG Sponsor AUROBINDO PHARMA Submission history Latest submission status date: 2024-03-28 00:00:00.
Structured Monograph
Clinical summary
Approval overview AUROVELA FE 1/20 is listed in Drugs@FDA under application 207505 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ETHINYL ESTRADIOL; NORETHINDRONE ACETATE Form and strength TABLET;ORAL-28 - 0.02MG;1MG Sponsor AUROBINDO PHARMA Submission history Latest submission status date: 2024-03-28 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.